• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Development of a useful tool adding a microbial component to tumor cell as vaccine adjuvant

Research Project

  • PDF
Project/Area Number 20200075
Research Category

Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)

Allocation TypeSingle-year Grants
Research Field Experimental pathology
Biological pharmacy
Research InstitutionResearch Institute, Osaka Medical Center for Cancer and Cardiovascular Disaeses

Principal Investigator

AKAZAWA Takashi  地方独立行政法人大阪府立病院機構大阪府立成人病センター(研究所), 研究所, 研究員 (80359299)

Co-Investigator(Renkei-kenkyūsha) INOUE Norimitsu  地方独立行政法人大阪府立病院機構大阪府立成人病センター(研究所), 研究所, 部長 (80252708)
Project Period (FY) 2008 – 2010
Keywords腫瘍 / アジュバント / ワクチン
Research Abstract

It is essential to develop effective immunoadjuvants for tumor immunotherapy. We created new adjuvants based on the structure of mycoplasmal lipopeptide, which is a toll-like receptor (TLR) 2 ligand. Adjuvant engineering, substituting a functional motif for bacterial origin sequence of lipopeptide, is our novel drug design strategy. We succeeded in development of useful synthetic adjuvants through the evaluation of new TLR2 ligands with additional functions such as targeting ability to immune cells or modification ability to tumor cells.

  • Research Products

    (19 results)

All 2011 2010 2009 2008 Other

All Journal Article (10 results) (of which Peer Reviewed: 10 results) Presentation (6 results) Remarks (3 results)

  • [Journal Article] Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR22011

    • Author(s)
      Sawahata R, Shime H, Yamazaki S, Inoue N, Akazawa T, Fujimoto Y, Fukase K, Matsumoto M, Seya T.
    • Journal Title

      Microbes Infect.

      Volume: 13(4) Pages: 350-8

    • Peer Reviewed
  • [Journal Article] IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid2011

    • Author(s)
      Yabu M, Shime H, Hara H, Saito T, Matsumoto M, Seya T, Akazawa T, Inoue N.
    • Journal Title

      Int Immunol.

      Volume: 23(1) Pages: 29-41

    • Peer Reviewed
  • [Journal Article] IFN-gamma markedly cooperates with intratumoral dendritic cell vaccine in dog tumormodels2010

    • Author(s)
      Mito K, Sugiura K, Ueda K,Hori T, Akazawa T, Yamate J, Nakagawa H, Hatoya S, Inaba M, Inoue N, IkeharaS, Inaba T.
    • Journal Title

      Cancer Res.

      Volume: 70(18) Pages: 7093-101

    • Peer Reviewed
  • [Journal Article] Effect of IL-12 on canine dendritic cell maturation following differentiation induced by granulocyte-macrophage CSF and IL-42010

    • Author(s)
      Sugiura K, Wijewardana V, Fujimoto M, Akazawa T, Yahata M, Mito K, Hatoya S, Inoue N, Inaba T.
    • Journal Title

      Vet Immunol Immunopathol.

      Volume: 137(3-4) Pages: 322-6

    • Peer Reviewed
  • [Journal Article] Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion2010

    • Author(s)
      Akazawa T, Inoue N, Shime H, Kodama K, Matsumoto M, Seya T.
    • Journal Title

      Cancer Sci.

      Volume: 101(7) Pages: 1596-603

    • Peer Reviewed
  • [Journal Article] Two-step colocalization of MORC3 with PML nuclear bodies2010

    • Author(s)
      Mimura Y, Takahashi K, Kawata K, Akazawa T,Inoue N.
    • Journal Title

      J Cell Sci.

      Volume: 123(Pt12) Pages: 2014-241

    • Peer Reviewed
  • [Journal Article] Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice2009

    • Author(s)
      Akao Y, Ebihara T, Masuda H, Saeki Y, Akazawa T, Hazeki K, Hazeki O, Matsumoto M, Seya T.
    • Journal Title

      Cancer Sci.

      Volume: 100(8) Pages: 1494-501

    • Peer Reviewed
  • [Journal Article] Innate immune therapy with a Bacillus Calmette-Guerin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study2009

    • Author(s)
      Kodama K, Higashiyama M, TakamiK, Oda K, Okami J, Maeda J, Akazawa T, Matsumoto M, Seya T, Wada M, Toyoshima K.
    • Journal Title

      Surg Today.

      Volume: 39(3) Pages: 194-200

    • Peer Reviewed
  • [Journal Article] Construction of an expression vector for improved secretion of canine IL-182008

    • Author(s)
      Sugiura K, Akazawa T, Fujimoto M, Wijewardana V, Mito K, Hatoya S, Taketani S, Komori M, Inoue N, Inaba T.
    • Journal Title

      Vet Immunol Immunopathol.

      Volume: 126(3-4) Pages: 388-91

    • Peer Reviewed
  • [Journal Article] Tumor-secreted lactic acid promotes IL-23/1L-17 proinflammatory pathway2008

    • Author(s)
      Shime H, Yabu M, Akazawa T, Kodama K, Matsumoto M, Seya T, Inoue N.
    • Journal Title

      J Immunol.

      Volume: 180(11) Pages: 7175-83

    • Peer Reviewed
  • [Presentation] Adjuvant engineering for cancer immunotherapy: development of a synthetic TLR2 ligand with alternative functions2010

    • Author(s)
      Akazawa T, Inoue N.
    • Organizer
      第5回国際ペプチドシンポジウム(ポスター)
    • Place of Presentation
      京都
    • Year and Date
      20101204-09
  • [Presentation] Adjuvant engineering for cancer immunotherapy: development of a synthetic TLR2 ligand with alternative functions2010

    • Author(s)
      Akazawa T, Inoue N, Kodama K, Matsumoto M, Seya T.
    • Organizer
      第69回日本癌学会学術総会(ポスター)
    • Place of Presentation
      大阪
    • Year and Date
      20100922-24
  • [Presentation] Adjuvant engineering for cancer immunotherapy : development of a synthetic TLR2 ligand with additional function2010

    • Author(s)
      Akazawa T, Inoue N, Shime H, Kodama K, Matsumoto M, Seya T.
    • Organizer
      第14回国際免疫学会(ポスター)
    • Place of Presentation
      神戸
    • Year and Date
      20100822-27
  • [Presentation] A synthetic TLR2 ligand containing the RGD motif works as an effective adjuvant2009

    • Author(s)
      Akazawa T, Inoue N, Shime H, Kodama K, Matsumoto M, Seya T.
    • Organizer
      第68回日本癌学会学術総会(ポスター)
    • Place of Presentation
      横浜
    • Year and Date
      20091001-03
  • [Presentation] インテグリン結合モチーフを含む人工設計リポペプチドはトル様受容体2のリガンドとして機能し、効果的なアジュバント活性を持つ2009

    • Author(s)
      赤澤隆
    • Organizer
      第13回日本がん免疫学会(一般口演)
    • Place of Presentation
      北九州
    • Year and Date
      20090624-25
  • [Presentation] Development of designed synthetic adjuvants based on structures of toll-like receptor ligands2008

    • Author(s)
      Akazawa T, Inoue N, Matsumoto M, Seya T.
    • Organizer
      第67回日本癌学会学術総会(ポスター)
    • Place of Presentation
      名古屋
    • Year and Date
      20081028-30
  • [Remarks] 地方独立行政法人大阪府立病院機構大阪府立成人病センター

    • URL

      http://www.mc.pref.osaka.jp

  • [Remarks] 研究所

    • URL

      http://www.mc.pref.osaka.jp/omc2/top.html

  • [Remarks] 分子遺伝学部門

    • URL

      http://www.mc.pref.osaka.jp/omc2/genetics.html

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi